{"id":"boostrix-polio-711866","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Injection site pain"},{"rate":"20-30","effect":"Injection site redness"},{"rate":"15-25","effect":"Injection site swelling"},{"rate":"20-30","effect":"Myalgia"},{"rate":"15-25","effect":"Headache"},{"rate":"10-20","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is an inactivated vaccine containing antigens from Corynebacterium diphtheriae toxoid, Clostridium tetani toxoid, Bordetella pertussis (acellular), and inactivated poliovirus types 1, 2, and 3. Upon intramuscular injection, these antigens trigger both humoral and cellular immune responses, leading to the production of protective antibodies and memory B cells against these four pathogens.","oneSentence":"Boostrix Polio is a combined vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:45.456Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"}]},"trialDetails":[{"nctId":"NCT00635128","phase":"PHASE4","title":"Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02-01","conditions":"Poliomyelitis, Diphtheria, Tetanus","enrollment":415},{"nctId":"NCT00871000","phase":"PHASE3","title":"Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-04-01","conditions":"Acellular Pertussis, Tetanus, Diphtheria","enrollment":303}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["dTpa-IPV"],"phase":"phase_3","status":"active","brandName":"Boostrix Polio™ 711866","genericName":"Boostrix Polio™ 711866","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Biologic","firstApprovalDate":"","aiSummary":"Boostrix Polio is a combined vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus. Used for Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}